1. Home
  2. NXL vs HXHX Comparison

NXL vs HXHX Comparison

Compare NXL & HXHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • HXHX
  • Stock Information
  • Founded
  • NXL 2010
  • HXHX 2003
  • Country
  • NXL United States
  • HXHX China
  • Employees
  • NXL N/A
  • HXHX N/A
  • Industry
  • NXL Medical Specialities
  • HXHX Trucking Freight/Courier Services
  • Sector
  • NXL Health Care
  • HXHX Industrials
  • Exchange
  • NXL Nasdaq
  • HXHX Nasdaq
  • Market Cap
  • NXL 17.8M
  • HXHX 16.8M
  • IPO Year
  • NXL 2022
  • HXHX 2025
  • Fundamental
  • Price
  • NXL $0.93
  • HXHX $1.46
  • Analyst Decision
  • NXL Strong Buy
  • HXHX
  • Analyst Count
  • NXL 1
  • HXHX 0
  • Target Price
  • NXL $5.00
  • HXHX N/A
  • AVG Volume (30 Days)
  • NXL 191.8K
  • HXHX 243.4K
  • Earning Date
  • NXL 11-07-2025
  • HXHX 01-01-0001
  • Dividend Yield
  • NXL N/A
  • HXHX N/A
  • EPS Growth
  • NXL N/A
  • HXHX N/A
  • EPS
  • NXL N/A
  • HXHX 0.26
  • Revenue
  • NXL $174,813.00
  • HXHX $25,571,810.00
  • Revenue This Year
  • NXL $38.28
  • HXHX N/A
  • Revenue Next Year
  • NXL $185.71
  • HXHX N/A
  • P/E Ratio
  • NXL N/A
  • HXHX $5.61
  • Revenue Growth
  • NXL 16.42
  • HXHX N/A
  • 52 Week Low
  • NXL $0.59
  • HXHX $0.84
  • 52 Week High
  • NXL $4.49
  • HXHX $6.29
  • Technical
  • Relative Strength Index (RSI)
  • NXL 52.06
  • HXHX N/A
  • Support Level
  • NXL $0.86
  • HXHX N/A
  • Resistance Level
  • NXL $0.97
  • HXHX N/A
  • Average True Range (ATR)
  • NXL 0.08
  • HXHX 0.00
  • MACD
  • NXL 0.00
  • HXHX 0.00
  • Stochastic Oscillator
  • NXL 48.80
  • HXHX 0.00

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

Share on Social Networks: